ML24131A124
| ML24131A124 | |
| Person / Time | |
|---|---|
| Site: | Palisades  |
| Issue date: | 05/10/2024 |
| From: | Justin Poole Plant Licensing Branch III |
| To: | Fleming J Holtec |
| Wall S | |
| References | |
| Download: ML24131A124 (3) | |
Text
May 10, 2024 Jean A. Fleming Vice President, Licensing, Regulatory Affairs, and PSA Holtec International, LLC Krishna P. Singh Technology Campus 1 Holtec Boulevard Camden, NJ 08104
SUBJECT:
REQUEST FOR WITHHOLDING INFORMATION FROM PUBLIC DISCLOSURE FOR PALISADES NUCLEAR PLANT
Dear Jean A. Fleming:
By [[letter::PNP 2024-023, Pre-Submittal Meeting Presentation - License Amendment Request to Approve the Biasi Critical Heat Flux (CHF) Correlation for Use with the Palisades Main Steam Line Break (MSLB) Analysis|letter dated May 9, 2024]], Holtec Decommissioning International, LLC (HDI), on behalf of Framatome Inc., submitted an affidavit dated May 7, 2024, executed by Morris Byram, Manager of Licensing and Regulatory Affairs, requesting that the information contained in the following document be withheld from public disclosure pursuant to Section 2.390 of Title 10 of the Code of Federal Regulations (10 CFR):
Pre-Submittal Meeting Presentation (closed session) - Palisades Nuclear Plant License Amendment Request to Approve the Biasi Critical Heat Flux (CHF)
Correlation for Use with the Palisades Main Steam Line Break (MSLB) Analysis -
(Proprietary Information - Withhold Under 2.390)
A nonproprietary copy of this document has been placed in the U.S. Nuclear Regulatory Commissions (NRCs) Public Document Room and added to the NRC Library in the Agencywide Documents Access and Management System (ADAMS) at Accession No. ML24130A145.
The affidavit stated that the submitted information should be considered exempt from mandatory public disclosure for the following reasons:
The information reveals certain distinguishing aspects of a process, methodology, or component, the exclusive use of which provides a competitive advantage for Framatome in product optimization or marketability.
The information is vital to a competitive advantage held by Framatome, would be helpful to competitors to Framatome, and would likely cause substantial harm to the competitive position of Framatome.
We have reviewed your application and the material in accordance with the requirements of 10 CFR 2.390 and, on the basis of the statements in the affidavit, have determined that the
submitted information sought to be withheld contains proprietary commercial information and should be withheld from public disclosure.
Therefore, the version of the submitted information marked as proprietary will be withheld from public disclosure pursuant to 10 CFR 2.390(b)(5) and Section 103(b) of the Atomic Energy Act of 1954, as amended.
Withholding from public inspection shall not affect the right, if any, of persons properly and directly concerned to inspect the documents. If the need arises, we may send copies of this information to our consultants working in this area. We will, of course, ensure that the consultants have signed the appropriate agreements for handling proprietary information.
If the basis for withholding this information from public inspection should change in the future such that the information could then be made available for public inspection, you should promptly notify the NRC. You also should understand that the NRC may have cause to review this determination in the future, for example, if the scope of a Freedom of Information Act request includes your information. In all review situations, if the NRC makes a determination adverse to the above, you will be notified in advance of any public disclosure.
If you have any questions regarding this matter, I may be reached at 301-415-2048.
Sincerely,
/RA/
Justin C. Poole, Project Manager Plant Licensing Branch III Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket No.: 50-255 cc: Listserv
ML24131A124 OFFICE NRR/DORL/LPL3/PM NRR/DORL/LPL3/LA NRR/DORL/LPL3/BC NRR/DORL/LPL3/PM NAME JPoole SRohrer (SLent for)
JWhited JPoole DATE 05/09/2024 05/10/2024 05/10/2024 05/10/2024